Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
Sasol
SSL
$7.5B
| $96.2K | ﹤0.01% |
6,124
+2,300
| +60% | +$38.1K |
|
4102
PetMed Express
PETS
$41.7M
| $96K | ﹤0.01% |
5,421
+4,565
| +533% | +$90.7K |
|
4103
Lifestance Health
LFST
$4B
| $95.8K | ﹤0.01% |
19,401
+16,337
| +533% | +$101K |
|
4104
Republic Bancorp
RBCAA
$1.95B
| $95.6K | ﹤0.01% |
2,337
+1,860
| +390% | +$79.5K |
|
4105
U-Haul Holding Co
UHAL
$13.9B
| $95.5K | ﹤0.01% |
1,586
-68,134
| -98% | -$3.92M |
|
4106
NextCure
NXTC
$16.8M
| $95.3K | ﹤0.01% |
5,630
-44
| -0.8% | -$1.01K |
|
4107
Ponce Financial Group
PDLB
$488M
| $95.2K | ﹤0.01% |
10,212
+4,114
| +67% | +$39.2K |
|
4108
Babcock & Wilcox
BW
$1.39B
| $94.7K | ﹤0.01% |
16,416
+13,740
| +513% | +$75K |
|
|
ORC
4109
Orchid Island Capital
ORC
$1.3B
| $94.7K | ﹤0.01% |
9,018
+7,509
| +498% | +$76.5K |
|
4110
Johnson Outdoors
JOUT
$491M
| $94.7K | ﹤0.01% |
1,432
-2,807
| -66% | -$158K |
|
4111
Lightspeed Commerce
LSPD
$1.31B
| $94.5K | ﹤0.01% |
6,606
-32,197
| -83% | -$525K |
|
|
SMLR
4112
DELISTED
Semler Scientific
SMLR
| $94.3K | ﹤0.01% |
2,858
+2,556
| +846% | +$88.7K |
|
4113
Voyager Therapeutics
VYGR
$183M
| $94.3K | ﹤0.01% |
15,461
+13,563
| +715% | +$77.1K |
|
4114
Aviat Networks
AVNW
$265M
| $93.8K | ﹤0.01% |
3,006
+2,538
| +542% | +$77.1K |
|
|
LOGC
4115
DELISTED
ContextLogic
LOGC
| $93.4K | ﹤0.01% |
6,385
+3,879
| +155% | +$79.7K |
|
4116
Funko
FNKO
$326M
| $93.3K | ﹤0.01% |
8,549
+7,199
| +533% | +$101K |
|
4117
Matrix Service
MTRX
$326M
| $93.1K | ﹤0.01% |
14,961
+5,307
| +55% | +$27.4K |
|
4118
Utah Medical Products
UTMD
$225M
| $93K | ﹤0.01% |
925
+779
| +534% | +$71.1K |
|
4119
Centrus Energy
LEU
$3.48B
| $92.9K | ﹤0.01% |
2,859
+2,407
| +533% | +$91.8K |
|
|
DHC
4120
Diversified Healthcare Trust
DHC
$2.15B
| $92.6K | ﹤0.01% |
143,214
+30,837
| +27% | +$30.4K |
|
4121
Citizens & Northern Corp
CZNC
$456M
| $92.6K | ﹤0.01% |
4,052
+2,014
| +99% | +$48.2K |
|
4122
Anavex Life Sciences
AVXL
$255M
| $92.6K | ﹤0.01% |
10,000
-179,290
| -95% | -$1.92M |
|
|
ROVR
4123
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $92.3K | ﹤0.01% |
25,162
+21,230
| +540% | +$91K |
|
|
AHT
4124
Ashford Hospitality Trust
AHT
$20.9M
| $92.1K | ﹤0.01% |
2,061
+1,187
| +136% | +$76.5K |
|
4125
Five Star Bancorp
FSBC
$1.14B
| $92.1K | ﹤0.01% |
3,380
+2,846
| +533% | +$79.7K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.